Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationalized polytherapy for epilepsy

P Goldsmith1, P R de Bittencourt

  • 1Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK.

Acta Neurologica Scandinavica. Supplementum
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal transplantation in older adults: retrospective cohort study to examine the impact of the new 2019 kidney offering scheme on older adult transplant recipients.

Annals of the Royal College of Surgeons of England·2024
Same author

The reorganisation of emergency general surgery services during the COVID-19 pandemic in the UK: outcomes of delayed presentation, socio-economic deprivation and Black, Asian and Minority Ethnic patients.

Annals of the Royal College of Surgeons of England·2022
Same author

Occupational dermatoses during the second wave of the COVID-19 pandemic: a UK prospective study of 805 healthcare workers.

The British journal of dermatology·2021
Same author

Pyodermatitis vegetans-pyostomatitis vegetans with ocular involvement.

Clinical and experimental dermatology·2020
Same author

Congenital diaphragmatic hernia causing cardiac arrest in a 30-year-old woman.

Annals of the Royal College of Surgeons of England·2016
Same author

An unusual cause of plantar pustulosis.

Clinical and experimental dermatology·2016
Same journal

Sleep quality and arousal in migraine and tension-type headache: the headache-sleep study.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

Diffusion-weighted lesions in acute ischaemic stroke patients with migraine.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

Mild stroke: safety and outcome in patients receiving thrombolysis.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

Advances in genetic diagnosis of neurological disorders.

Acta neurologica Scandinavica. Supplementum·2014
See all related articles

Vigabatrin add-on therapy significantly reduced seizure frequency in 73% of patients with refractory partial epilepsy. This epilepsy treatment showed no harmful effects and even improved visual memory in some patients.

Area of Science:

  • Neurology
  • Pharmacology
  • Epilepsy Research

Background:

  • Historically, epilepsy treatment favored monotherapy due to concerns about drug interactions and side effects with polytherapy.
  • Recent advancements in well-tolerated anti-epileptic drugs have prompted a re-evaluation of polytherapy approaches.
  • A rationalized polytherapy strategy is emerging based on extensive clinical trials.

Purpose of the Study:

  • To evaluate the efficacy and safety of vigabatrin as an add-on therapy for patients with refractory partial epilepsy.
  • To assess the impact of vigabatrin on seizure frequency and cognitive function in a specific patient cohort.

Main Methods:

  • A study involving 19 patients with refractory partial epilepsy who were socially active.
  • Patients received vigabatrin as add-on therapy to their existing anti-epileptic drug regimen (mean 1.5 drugs).

Related Experiment Videos

  • Comprehensive laboratory, EEG, and cognitive function tests were conducted to assess safety and effects.

    • Main Results:

    • 73% of patients experienced a >50% reduction in seizure frequency with vigabatrin add-on therapy.
    • 52% of patients achieved a >70% reduction in seizure frequency.
    • No harmful effects were observed; a minor improvement in visual memory was noted, likely due to seizure reduction.

    Conclusions:

    • Vigabatrin as add-on therapy can be beneficial for patients with partial epilepsy refractory to standard monotherapy.
    • The drug demonstrated a favorable safety profile, with no adverse effects on laboratory, EEG, or cognitive tests.
    • The findings support a revised, rationalized approach to polytherapy in epilepsy management.